Jeffrey L. Tate
Known title: DirectorCIK: 0001699485
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Dow Inc. Announces 35¢ Quarterly Dividend Amid 43% Gain. Dow Inc. just declared a 35‑cent quarterly dividend, keeping its 5.42% yield. The stock has risen 43% this year, and Barclays has added coverage with an underweight rating and a $30 target. Analysts expect earnings growth and the company remains a dividend play for income investors. The move comes as the market dips and the stock sits near key support at $29.62.
Transaction History
| HBAN | ▲ Buy | Grant | 632 | $0 | 10/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 54 | $0 | 10/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 526 | $0 | 7/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 44 | $0 | 7/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 9,320 | $0 | 5/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 504 | $0 | 4/1/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 50 | $0 | 4/1/2026 | View on chart |
| DOW | ▲ Buy | Grant | 21,200 | $0 | 2/12/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 454 | $0 | 1/2/2026 | View on chart |
| HBAN | ▲ Buy | Grant | 45 | $0 | 1/2/2026 | View on chart |
| DOW | ▼ Sell | Other | 524 | $12K | 11/28/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 45 | $0 | 10/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 461 | $0 | 10/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 453 | $0 | 7/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 46 | $0 | 7/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 9,404 | $0 | 5/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 419 | $0 | 4/1/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 52 | $0 | 4/1/2025 | View on chart |
| DOW | ▲ Buy | Grant | 17,650 | $0 | 2/13/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 382 | $0 | 1/2/2025 | View on chart |
| HBAN | ▲ Buy | Grant | 46 | $0 | 1/2/2025 | View on chart |
| DOW | ▼ Sell | Other | 2,426 | $107K | 11/29/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 429 | $0 | 10/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 52 | $0 | 10/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 461 | $0 | 7/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 56 | $0 | 7/1/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 10,073 | $0 | 5/1/2024 | View on chart |
| DOW | ▲ Buy | Grant | 10,670 | $0 | 2/15/2024 | View on chart |
| HBAN | ▲ Buy | Grant | 12,511 | $0 | 5/1/2023 | View on chart |
| HBAN | ▲ Buy | Grant | 10,456 | $0 | 5/1/2022 | View on chart |
| HBAN | ▲ Buy | Grant | 1,847 | $29K | 1/26/2022 | View on chart |
| HBAN | ▲ Buy | Grant | 1,801 | $29K | 11/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
HBAN Earnings Outlook and Valuation Concerns Highlighted
Analysts expect Huntington Bancshares' third‑quarter earnings to decline, prompting a view that the stock may trade below its fair value. A recent valuation note suggests the shares are about 21 % undervalued based on current earnings multiples. The company also appears on lists of high‑yield dividend stocks, with a 5.7 % yield, which may attract income‑focused investors. These factors keep the stock in focus as the earnings release approaches.
HBAN Earnings Outlook and Valuation Concerns Highlighted. Analysts expect Huntington Bancshares' third‑quarter earnings to decline, prompting a view that the stock may trade below its fair value. A recent valuation note suggests the shares are about 21 % undervalued based on current earnings multiples. The company also appears on lists of high‑yield dividend stocks, with a 5.7 % yield, which may attract income‑focused investors. These factors keep the stock in focus as the earnings release approaches.